+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 65Years
All Genders
ID07191145

Early Intravenous Infusion of Eptinezumab to Prevent Persistent Post-Traumatic Headaches After Mild Traumatic Brain Injury A Randomized, Double-Blind, Placebo-Controlled Trial

Led by Sunnybrook Health Sciences Centre · Updated on 2026-10-29

80

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying post-traumatic headaches PTH that occur after mild traumatic brain injury mTBI, focusing on the migraine type which is the most disabling and often becomes chronic and resistant to treatment. This trial evaluates eptinezumab, a monoclonal antibody that blocks calcitonin gene-related peptide CGRP, which is involved in migraine and PTH symptoms. The study aims to see if early infusion of eptinezumab within 8 weeks of PTH onset can reduce headache frequency three months later and prevent persistent PTH. Participants will receive either a single intravenous infusion of 300 mg eptinezumab or a placebo within 8 weeks after the onset of post-traumatic headache. The study is randomized, double-blind, and placebo-controlled, comparing the effects of this treatment against placebo. The intervention is designed to act quickly, with eptinezumab having rapid onset and prolonged therapeutic effect compared to other treatments. During the study, participants will be monitored for headache frequency, responder rates, treatment use, headache disability, concussion severity, emotional function, patient satisfaction, and sleep quality for up to 24 weeks. Assessments include weekly calls for migraine screening and evaluations at multiple time points after treatment. Safety and adherence to treatment will also be observed throughout the trials duration.

CONDITIONS

Brief Title

Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (ELITE-ACT)

Research Team

H

Howard Meng, MD

L

Lavarnan Sivanathan, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here